<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01463748</url>
  </required_header>
  <id_info>
    <org_study_id>CS11074</org_study_id>
    <nct_id>NCT01463748</nct_id>
  </id_info>
  <brief_title>Effects of Graptopetalum Paraguayense E. Walther on the Oxidative Stress, Antioxidant Enzyme Activity and Inflammation in Subjects With Metabolic Syndrome</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chung Shan Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Science Council, Taiwan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chung Shan Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Metabolic syndrome (MS) is a significant risk factor of cardiovascular disease. The purposes
      of this study are going to investigate the effects of Graptopetalum paraguayense E. Walther
      on the oxidative stress, antioxidant enzyme activity and inflammation in subjects with
      metabolic syndromerelation. The investigators will recruit MS patients(n=50)and the inclusion
      criteria of MS are according to the Bureau of Health Promotion, Department of Health in
      Taiwan (2007). The MS subjects are randomly assigned to placebo(n=25) and Graptopetalum
      paraguayense E. Walther supplements(n=25)groups. Hopefully, the results of this study could
      provide the information of Graptopetalum paraguayense E. Walther supplements to what has been
      know in MS subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2011</start_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Antioxidant and inflammation</measure>
    <time_frame>12 weeks</time_frame>
    <description>The study are going to measure the concentrations of lipid peroxidation markers (TBARS and ox-LDL) and antioxidant enzymes activities (catalase, glutathione peroxidase, and superoxide dismutase), and the level of inflammatory markers (hs-CRP, TNF-alfa, IL-1, IL-6 and adiponectin) in all subjects of this study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood biochemical values</measure>
    <time_frame>12 weeks</time_frame>
    <description>Fasting glucose, blood pressure, and blood lipid profiles(total cholesterol, triglyceride, low density lipoprotein and high density lipoprotein).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">54</enrollment>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>starch</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Graptopetalum paraguayense E. Walther</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Graptopetalum paraguayense E. Walther</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Graptopetalum paraguayense E. Walther</intervention_name>
    <description>Graptopetalum paraguayense E. Walther</description>
    <arm_group_label>Graptopetalum paraguayense E. Walther</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>starch</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>starch</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The inclusion criteria of MS in adult are according to the Bureau of Health Promotion,
             Department of Health in Taiwan (2007), if subjects had 3 of the following 5
             characteristics: (1) abdominal obesity (waist circumference &gt;= 90 cm in men and &gt;= 80
             cm in women), (2) impaired fasting glucose ( &gt;= 5.6 mmol/L), (3) hypertriglyceridemia
             ( &gt;= 1.7 mmol/L), (4) low HDL-C (&lt; 1.0 mmol/L in men and &lt; 1.3 mmol/L in women), and
             (5) increased blood pressure (SBP &gt;= 130 mmHg and DBP &gt;= 85 mmHg). Subjects using
             antidiabetic or antihypertensive or lipid-lowering medications were considered to have
             elevated fasting blood glucose or elevated blood pressures or dyslipidemia,
             respectively.

        Exclusion Criteria:

          -  Subjects with liver, renal diseases, undergoing statin therapy, pregnancy women, and
             taking antioxidant vitamins supplements were excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Chung Shan Medical University</name>
      <address>
        <city>Taichung</city>
        <zip>40201</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2011</study_first_submitted>
  <study_first_submitted_qc>October 31, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2011</study_first_posted>
  <last_update_submitted>July 2, 2013</last_update_submitted>
  <last_update_submitted_qc>July 2, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 3, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chung Shan Medical University</investigator_affiliation>
    <investigator_full_name>Chun-Yu Yeh</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

